Victory Capital Management Portfolio holdings
AUM
$155B
1-Year Return
20.6%
This Quarter Return
+9.24%
1 Year Return
+20.6%
3 Year Return
+77.5%
5 Year Return
+161.59%
10 Year Return
+412.71%
AUM
$109B
AUM Growth
+$6.58B
(+6.4%)
Cap. Flow
-$2.5B
Cap. Flow
% of AUM
-2.3%
Top 10 Holdings %
Top 10 Hldgs %
11.22%
Holding
2,921
New
123
Increased
1,147
Reduced
1,381
Closed
157
Top Buys
| 1 |
Global Payments
GPN
|
$375M |
| 2 |
Coterra Energy
CTRA
|
$292M |
| 3 |
Progressive
PGR
|
$240M |
| 4 |
Hilton Worldwide
HLT
|
$222M |
| 5 |
Live Nation Entertainment
LYV
|
$214M |
Top Sells
| 1 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$373M |
| 2 |
XEC
CIMAREX ENERGY CO
XEC
|
$331M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$199M |
| 4 |
Highwoods Properties
HIW
|
$196M |
| 5 |
Americold
COLD
|
$166M |
Sector Composition
| 1 | Technology | 17.81% |
| 2 | Industrials | 13.97% |
| 3 | Financials | 11.96% |
| 4 | Consumer Discretionary | 10.9% |
| 5 | Healthcare | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGIO
2601
DELISTED
Edgio, Inc. Common Stock
EGIO
| $63K | ﹤0.01% |
457
+15
| +3% | +$2.07K |
|
2602
Accuray
ARAY
$170M
| $59K | ﹤0.01% |
12,301
-13,732
| -53% | -$65.9K |
|
2603
Lineage Cell Therapeutics
LCTX
$279M
| $58K | ﹤0.01% |
23,539
-574
| -2% | -$1.41K |
|
2604
Nerdy
NRDY
$163M
| $56K | ﹤0.01% |
+12,400
| New | +$56K |
|
2605
Precigen
PGEN
$1.3B
| $56K | ﹤0.01% |
15,038
-460
| -3% | -$1.71K |
|
|
MKFG
2606
DELISTED
Markforged Holding Corporation
MKFG
| $55K | ﹤0.01% |
1,027
-1,029
| -50% | -$55.1K |
|
2607
Akebia Therapeutics
AKBA
$785M
| $53K | ﹤0.01% |
23,670
-677
| -3% | -$1.52K |
|
2608
Geron
GERN
$893M
| $53K | ﹤0.01% |
43,555
-1,167
| -3% | -$1.42K |
|
2609
Workhorse Group
WKHS
$19.4M
| $52K | ﹤0.01% |
+48
| New | +$52K |
|
2610
Rigel Pharmaceuticals
RIGL
$742M
| $51K | ﹤0.01% |
1,916
-57
| -3% | -$1.52K |
|
2611
Verastem
VSTM
$663M
| $51K | ﹤0.01% |
2,076
-48
| -2% | -$1.18K |
|
2612
Ceco Environmental
CECO
$1.67B
| $50K | ﹤0.01% |
7,957
+436
| +6% | +$2.74K |
|
2613
GeneDx Holdings
WGS
$3.81B
| $50K | ﹤0.01% |
340
-9
| -3% | -$1.32K |
|
2614
Spire Global
SPIR
$276M
| $49K | ﹤0.01% |
1,831
-55
| -3% | -$1.47K |
|
|
CLVS
2615
DELISTED
Clovis Oncology, Inc.
CLVS
| $48K | ﹤0.01% |
17,774
+1,078
| +6% | +$2.91K |
|
2616
Kopin
KOPN
$345M
| $47K | ﹤0.01% |
11,534
-268
| -2% | -$1.09K |
|
2617
NextDecade
NEXT
$2.8B
| $47K | ﹤0.01% |
16,573
-148
| -0.9% | -$420 |
|
2618
Xeris Biopharma Holdings
XERS
$1.27B
| $47K | ﹤0.01% |
+15,965
| New | +$47K |
|
2619
The Beachbody Company, Inc. Class A Common Stock
BODI
$40.8M
| $46K | ﹤0.01% |
387
-14
| -3% | -$1.66K |
|
|
BBIG
2620
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
| $45K | ﹤0.01% |
1,378
+402
| +41% | +$13.1K |
|
|
BIOR
2621
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $45K | ﹤0.01% |
87
+30
| +53% | +$15.5K |
|
2622
MEI Pharma
MEIP
$139M
| $44K | ﹤0.01% |
824
+140
| +20% | +$7.48K |
|
|
BKCC
2623
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $43K | ﹤0.01% |
10,761
-354
| -3% | -$1.42K |
|
2624
W&T Offshore
WTI
$261M
| $41K | ﹤0.01% |
12,634
-17,672
| -58% | -$57.3K |
|
2625
Cartesian Therapeutics
RNAC
$277M
| $40K | ﹤0.01% |
407
-7
| -2% | -$688 |
|